Since its inception, the Buffalo Neuroimaging Analysis Center (BNAC) has established itself as a world leader in global and regional quantitative brain measurements in multiple sclerosis (MS) and other neurodegenerative disorders diseases and disorders. BNAC uses innovative imaging MRI techniques in conjunction with artificial intelligence (AI), as well as other translational approaches, such as optical coherence tomography (OCT) and positron emission tomography (PET).
The Center is committed to the development and application of cutting edge analysis techniques in all areas of neuroimaging that can aid in our understanding of the onset, progression, and treatment of these diseases and disorders. These include brain atrophy, iron imaging, structural and functional connectomics, and many others.
The BNAC also strives to develop real-world translational approaches, determine the predictivity of biomarkers, and investigate interactions between the nervous and cardiovascular systems to better understand their relationship to neurodegenerative neurological disease and aging, as well as clinical, MRI, and genetic correlates.